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Background
It has been reported that the prevalence of allergic diseases, including asthma, food allergy,
and allergic rhinitis (AR), is strongly associated with vitamin D deficiency. This study was
conducted to evaluate the relation between vitamin D levels and AR in Egyptian patients.

Patients and methods

A total of 100 AR cases and 50 healthy controls were included. Cases were subjected to
complete history taking and ENT examination. Vitamin D and immunoglobulin E levels were
ordered for both cases and controls.

Results

No significant difference was detected between cases and controls regarding demographics.
Regarding total nasal symptom score, it was mild in 44 cases, whereas 56 cases had moderate
to severe scores. Serum vitamin D levels were significantly lower in cases compared with
controls (16.9 vs. 28.3 ng/ml – P<0.001). Besides, vitamin D had lower levels in cases with
higher total nasal symptom score. Conversely, immunoglobulin E was significantly higher
in rhinitis cases compared with controls (1071.4 vs. 208.7 IU/ml – P<0.001). With a cutoff
value of 13.6 ng/ml, lower vitamin D levels had sensitivity and specificity of 95.7 and 82.2%,
respectively, to identify AR cases.

Conclusion

It is evident that low vitamin D levels are associated with AR. Moreover, the more deficiency
detected in its levels, the more severe symptoms experienced by patients.
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Introduction
Allergic rhinitis (AR) affects ~10–20% of the general
population, and its incidence keeps increasing. It is
an inflammatory disorder affecting the nasal mucosa,
and it is mediated by immunoglobulin E (IgE) after
exposure to allergens [1].
The severity of symptoms in AR cases could be
assessed subjectively via the total nasal symptom
score (TNSS) or objectively via estimating serum IgE
levels. Moderate to severe AR is present in ~67.5% of
the AR population and affects the quality of life [2].
Multiple studies have pointed to the association
between diminished vitamin D levels and allergic
disorders. Vitamin D deficiency is considered one of
the world health problems, and it can lead to acute and
chronic morbidities [3].
Vitamin D can play a role in the pathogenesis of AR,
as it has a crucial effect on the body’s immune cells.
A previous Indian research reported that vitamin
D deficiency was detected in 91% of AR cases [4];
nevertheless, other studies failed to detect this
relationship [5,6].

There is still a major controversy regarding this association.
Most studies reported that there was a strong association
between vitamin D deficiency and AR. Moreover, a
strong negative correlation was also reported between
serum vitamin D levels and TNSS [7,8].
Conversely, some other studies showed different results
in the response of interleukin (IL)‑4 and IL‑13 in
mice bronchoalveolar secrete after being given vitamin
D [9,10].
In other words, the relationship between serum
vitamin D levels with AR and TNSS is still unclear;
hence, further study is needed to obtain more accurate
results [11].
This study was conducted in Benha University
Hospitals aiming to evaluate the relation between
vitamin D levels and AR in Egyptian patients.
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Patients and methods
This is a case–control study that was conducted during
the period of 1 year (from January 2019 till January
2020) at the Otorhinolaryngology Department of
Benha University. We included 150 participants,
comprising 100 cases with AR (cases group) and 50
healthy controls (control group).
Cases with liver disease, kidney disease, pregnancy,
hypertension, paranasal sinusitis, septal deviation, or
respiratory tract infections were excluded from our
study.
An informed oral consent was obtained from all cases
and controls before participating in the study. Besides,
the study was approved by the local ethical committee
of Benha University.
All cases were subjected to complete history taking
and thorough ENT examination. The TNSS was
assessed for all cases [11]. Moreover, serum vitamin
D and IgE levels were ordered for both cases and
controls.
Serum vitamin D was measured using the
electrochemiluminescence immunoassays method
viaCobas E411 (fully automated) hormoneimmunoassay analyzer. For IgE levels, a 1470 Wizard
gamma‑counter (PerkinElmer, Helsinki, Finland), along
with ImmunoCAP 100 (Phadia, Sweden), was utilized.
Statistical analysis

The collected data were coded, processed, and
analyzed using the Statistical Package for Social
Sciences, version 22 for Windows (IBM SPSS Inc.,
Chicago, Illinois, USA). Data were tested for normal
distribution using the Shapiro–Wilk test. Qualitative
data were represented as frequencies and relative
percentages. 2 test was used to calculate difference
between two or more groups of qualitative variables.
Quantitative data were expressed as mean ± SD.
Independent samples t test was used to compare
between two independent groups of normally
distributed variables (parametric data). Receiver
operator characteristic curve was tested to calculate
the diagnostic ability of quantitative variable in
prediction of categorical outcome. P value less than
0.05 was considered significant.

Results
The mean age of the included cases was 29.4 years,
whereas it was 28.3 years for controls. We included
68 and 30 female cases in case and control groups,

respectively. No significant difference was detected
between cases and controls regarding these
parameters (P>0.05). Table 1 illustrates these data.
In the case group, most cases had persistent AR
symptoms (82%), whereas the rest of the cases had
intermittent symptoms. These data are illustrated in
Table 2.
Regarding TNSS, it was mild in 44 cases, whereas
56 cases had moderate to severe scores (Table 3).
It was evident that serum vitamin D levels was
significantly lower in cases compared with controls
(16.9 vs. 28.3 ng/ml – P<0.001). Table 4 shows these
data.
Conversely, IgE was significantly higher in rhinitis
cases compared with controls (1071.4 vs. 208.7 IU/ml –
P<0.001). Table 5 illustrates these data.
As illustrated in Table 6, on analyzing vitamin D
and IgE levels according to TNSS, it was evident
that cases with moderate to severe symptoms had
significantly higher IgE levels, and significantly
lower vitamin D levels, compared with cases with
mild disease.
With a cutoff value of 13.6 ng/ml, lower vitamin
D levels had sensitivity and specificity of 95.7 and
82.2%, respectively, to identify AR cases, with an
accuracy of 88.6%. Table 7 and Fig. 1 illustrate these
data.
Table 1 Comparison of the demographic data in the two
study groups
Test of
significance

P

20 (40)
30 (60)

χ2=2.106

0.124

29.4±6.65

28.3±5.32

t=1.087

0.275

21‑43

219‑39

Groups [n (%)]

Sex
Males
Females
Age (years)
Mean±SD

Allergic rhinitis
(n=100)

Control
group (n=50)

32 (32)
68 (68)

Range

Table 2 Analysis of allergic rhinitis classification in the cases
included in the study
Items

Cases with allergic rhinitis (n=100) [n (%)]

Intermittent

18 (18)

Persistent

82 (82)

Table 3 Analysis of total nasal symptom score in the cases
included in the study
Items

Cases with allergic rhinitis (n=100) [n (%)]

Mild

44 (44)

Moderate‑severe

56 (56)

Serum vitamin D deficiency and  allergic rhinosinusitis Kamel et al. 131
Table 4 Comparison of serum levels of vitamin D in the two study groups
Groups
Allergic rhinitis (n=100)

Control group (n=50)

16.9±6.18

28.3±6.32

8.3‑29.5

14.1‑43.4

Vitamin D Levels (ng/ml)
Mean±SD
Range

Table 5 Comparison of serum levels of immunoglobulin E in
the two study groups
Groups
Allergic rhinitis
Control
(n=100)
group (n=50)
IgE (IU/ml)
Mean±SD 1071.4±673.75 208.7±38.76
Range

503‑3006

161.4‑295.8

Test of
significance

Test of
significance

P

t=−6.043

<0.001**

Figure 1

P

t=11.765
<0.001**

IgE, immunoglobulin E.

Discussion
This study was conducted at Benha University
Hospitals aiming to evaluate the relation between
vitamin D levels and AR in Egyptian patients. We
included a total of 100 cases with AR in addition to
50 healthy controls.
Another study handling the same perspective included
a total of 50 AR cases together with 50 controls [12].
In the current study, no significant difference was
detected between cases and controls regarding
age (P=0.275). The mean age was 29.4 and 28.3 years
for cases and controls, respectively.
Another study also reported no significant difference
between cases and controls regarding age (P>0.05).
Age ranged between 8 and 64 years in cases, whereas
it ranged between 20 and 69 years in the control
group [13].
In another study, age was significantly different between
cases and controls (P<0.001). It had a mean of 28.387
and 35.33 years in cases and controls, respectively [11].
In our study, no significant difference was detected
between the two groups regarding sex (P=0.124).
Males represented 32 and 40% of cases and controls,
respectively.
In another study, there was no significant difference
between cases and controls regarding sex (P=0.20).
Males represented 76 and 86% of cases and controls,
respectively [12]. The study reported no significance
like ours. However, there was male predominance in
contrast to ours.
Regarding TNSS in the current study, it was mild in
44 (44%) cases, whereas 56 (56%) cases had moderate
to severe scores.

ROC curve for vitamin D levels to identify AR. AR, allergic rhinitis;
ROC, receiver operator characteristic.

In another study, mild TNSS score was detected in
five (33.33%) cases, whereas 10 (66.67%) cases had
moderate–severe TNSS score [11].
In our study, IgE was significantly higher in rhinitis
cases compared with controls (1071.4 vs. 208.7 IU/ml –
P<0.001).
In another study, raised IgE was detected in 76% of AR
cases, whereas it increased in only 12% of controls. There
was a significant increase in IgE levels in cases compared
with controls (553.5 vs. 219.4 IU/ml – P<0.001) [12].
This comes in line with our findings.
IgE, which mediates allergic immune responses, has
been shown to have an inverse relationship with serum
vitamin D levels. Patients with low levels of vitamin D
have high levels of IgE [14].
Milovanovic et al. [15] stated that there was a
significant negative correlation between serum vitamin
D levels and IgE. That study result was from the study
conducted by Yip et al. [7], which found that vitamin
D could suppress the activity of IgE‑mediated mast
cells.
Regarding vitamin D levels in the current study,
it was evident that serum vitamin D levels were
significantly lower in cases compared with controls
(16.9 vs. 28.3 ng/ml – P<0.001). With a cutoff value of
13.6 ng/ml, lower vitamin D levels had sensitivity and
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Table 6 Correlation between total nasal symptom score and vitamin D and immunoglobulin E levels
Groups
Mild ART (n=44)
Vitamin D levels (ng/ml)
IgE (IU/ml)

Moderate to severe (n=56)

Test of
significance

P

21.56±4.25

14.76±3.87

t=3.165

0.019*

698.76±216.98

1043.76±450.87

t=−8.188

<0.001**

IgE, immunoglobulin E.
Table 7 Analysis of the diagnostic ability of vitamin D levels
to identify allergic rhinitis
Diagnostic criteria

Data

AUC
Cut off point
Sensitivity
Specificity
PPV
NPV
Accuracy

0.954
<13.6
95.7%
82.2%
96.4%
94.3%
88.6%

P

0.001*

AUC, area under the curve; NPV, negative predictive value;
PPV, positive predictive value.

specificity of 95.7 and 82.2%, respectively, to identify
AR cases, with an accuracy of 88.6%.
There have been various reports of AR in children and
adults with low levels of vitamin D [16,17]. Similarly,
there have been reports of antenatal maternal vitamin
D deficiency with a higher incidence of atopy in
newborns [18].
The Nord‑Trøndelag Health Study (HUNT) was a
longitudinal cohort conducted in Norway. It collected
serum vitamin D levels at baseline and then followed the
individuals for around 11 years. In men, 9% developed
AR; the adjusted odds ratio was 2.55 at vitamin D
less than 50 nmol/l. In women, 15% developed AR;
however, the adjusted odds ratio was 0.83 for each 25
nmol/l reduction in vitamin D levels [19].
Another study also confirmed these findings, as the
mean levels of vitamin D were 9.13 and 26.22 ng/ml
in both cases and controls, respectively (P<0.001). The
receiver operator characteristic analysis curve showed
that the cutoff points related to AR were 12.83 ng/ml,
with 100% sensitivity and 80% specificity [11].
In a similar study, serum vitamin D levels were
significantly higher in controls compared with
cases (19.1 vs. 14.8 ng/ml – P=0.002) [12].
Another study has reported most AR cases had vitamin
D deficiency. The mean vitamin D levels in the study
group was found to be 14.7 ng/ml and 68% of patients
had vitamin D deficiency [20].
In a study performed in Iran, vitamin D levels were
assessed in 50 patients with AR, and the study results
were compared with vitamin D status in normal

population. The prevalence of severe vitamin D
deficiency was higher in patients with AR than in
normal population (30 and 5.1%, respectively) [13].
Some interventional studies have highlighted
the role of supplementation of vitamin D in the
alleviation of AR symptoms. In Heine et al. [21],
vitamin D supplementation in vitamin D‑deficient
mice resulted in immunomodulation, which favored
protection against allergic triggers. Production of
pro‑inflammatory cytokines was reduced and that of
anti‑inflammatory cytokines was increased by vitamin
D supplementation. Jerzyńska et al. [22] supplemented
children with vitamin D during the pollen season and
observed fewer manifestations of AR as compared
with the placebo group.
Furthermore, a study in India found that vitamin D
deficiency occurred in 91% of the total AR samples
and a significant improvement shown in TNSS after
vitamin D supplementation [23].
The mechanism of action of vitamin D can be
explained by its ability to control Th2‑mediated
cell regulation. It controls the APC by decreasing
lipopolysaccharide
activity,
enhancing
the
tolerogenic phenotype of dendritic cells, and
inhibiting APC differentiation [24]. Vitamin D
inhibits mast cell differentiation and can cause mast
cell apoptosis within 30–40 days. The inhibitory
pathway of other mast cells was by inhibiting IgE
and IL‑4 [25].
On the contrary, in a study with Turkish children,
the mean levels of vitamin D were significantly
higher in AR cases compared with non‑allergic
cases and controls (18.07±6.1 ng/ml in AR vs.
14.81±4.86 ng/ml in the non‑AR group, and
24.03±9.43 ng/ml in controls – P=0.001). More
children in non‑AR were vitamin D deficient as
compared with (AR 67 vs. 89%). Vitamin D levels did
not statistically correlate with allergen sensitivity and
AR duration and severity [5]. This contradicts with our
findings.
Furthermore, a previous meta‑analysis has concluded
that vitamin D level may not relate with neither the
prevalence of the current AR nor the development of
AR [6].

Serum vitamin D deficiency and  allergic rhinosinusitis Kamel et al. 133

In the current study, on analyzing vitamin D and IgE
levels according to TNSS, it was evident that cases
with moderate to severe symptoms had significantly
higher IgE levels, and significantly lower vitamin D
levels, compared with cases with mild disease. Vitamin
D had a mean level of 21.56 and 14.76 in mild and
moderate to severe cases, respectively (P=0.019).
In another study, there was a significant negative
relationship between serum vitamin D levels and
TNSS of the patients with AR (P<0.001). The
correlation coefficient (r) between the two variables
was −0.8, which indicated that the two variables had a
strong negative correlation [11]. This agrees with our
findings.
Furthermore, the results of this study were similarly
reported by the study by Thakkar et al. [8], which also
found a negative relationship between serum vitamin
D levels and TNSS with moderate correlation strength.

J Allergy Clin Immunol 2017; 139:472–481.
4 Modh D, Katarkar A, Thakkar B, Jain A, Shah P, Joshi K. Role of vitamin D
supplementation in allergic rhinitis. Indian J Allergy Asthma Immunol 2014;
28:35–38.
5 Dogru M, Suleyman A. Serum 25‑hydroxyvitamin D3 levels in children
with allergic or nonallergic rhinitis. Int J Pediatr Otorhinolaryngol 2016;
80:39–42.
6 Kim YH, Kim MJ, Sol IS, Yoon SH, Park YA, Kim KW, et al. Vitamin D
Level in allergic rhinitis: a systemic review and meta‑analysis. J Allergy
Clin Immunol 2016; 137:94–99
7 Yip KH, Kolesnikoff N, Yu C, Hauschild N, Taing H, Biggs L, et al.
Mechanisms of vitamin D3 metabolite repression of IgE‑dependent mast
cell activation. J Allergy Clin Immunol 2014; 133:1356–1364.
8 Thakkar B, Katarkar A, Modh D, Jain A, Shah P, Joshi K. Deficiency of
vitamin D in allergic‑rhinitis: a possible factor in multifactorial disease.
J Clin Rhinol 2014; 7:112–116.
9 Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A.
1, 25‑dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to
enhance the development of Th2 cells. J Immunol 2001; 167:4974–4980.
10 Topilski I, Flaishon L, Naveh Y, Harmelin A, Levo Y, Shachar I. The
anti-inflammatory effects of 1, 25-dihydroxyvitamin D3 on Th2 cells in vivo
are due in part to the control of integrin-mediated T lymphocyte homing.
Eur J Immunol 2004; 34:1068–1076.
11 Restimulia L, Pawarti DR, Ekorini HM. The relationship between serum
vitamin D levels with allergic rhinitis incidence and total nasal symptom
score in allergic rhinitis patients. Open Access Maced J Med Sci 2018;
6:1405–1409.

This study has some limitations. First of all, the sample
size was relatively small. Therefore, more studies
including more cases should be conducted in the future.
Second, cases with vitamin D deficiency should have
been treated with vitamin D to determine its effect on
AR improvement.

12 Ansari SF, Memon M, Brohi N, Kumar B. Vitamin D and serum
immunoglobulin E levels in allergic rhinitis: a case‑control study from
Pakistan. Cureus 2019; 11:495–498.

Conclusion
Based on our findings, it is evident that low
vitamin D levels are associated with AR. Moreover, the
more deficiency detected in its levels, the more severe
symptoms experienced by patients. These findings
encourage practitioners to correct vitamin D levels in
such cases.

16 Bener A, Ehlayel MS, Bener HZ, Hamid Q. The impact of vitamin D
deficiency on asthma, allergic rhinitis and wheezing in children: an
emerging public health problem. J Fam Comm Med 2014; 21:154–161.
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